{"id":40163,"date":"2022-12-23T09:29:47","date_gmt":"2022-12-23T09:29:47","guid":{"rendered":"https:\/\/positivelysharing.org\/blog\/?p=40163"},"modified":"2022-12-23T09:29:47","modified_gmt":"2022-12-23T09:29:47","slug":"sunlenca-lenacapavir-receives-fda-approval-as-a-first-in-class-twice-yearly-treatment-option-for-people-living-with-multi-drug-resistant-hiv","status":"publish","type":"post","link":"https:\/\/positivelysharing.org\/blog\/2022\/12\/23\/sunlenca-lenacapavir-receives-fda-approval-as-a-first-in-class-twice-yearly-treatment-option-for-people-living-with-multi-drug-resistant-hiv\/","title":{"rendered":"Sunlenca\u00ae (lenacapavir) Receives FDA Approval as a First-in-Class, Twice-Yearly Treatment Option for People Living With Multi-Drug Resistant HIV"},"content":{"rendered":"<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span><p><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-21472\" src=\"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/05\/GILEAD-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/05\/GILEAD-300x200.jpg 300w, https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/05\/GILEAD-500x333.jpg 500w, https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/05\/GILEAD.jpg 661w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Sunlenca<sup>\u00ae<\/sup> (lenacapavir), in combination with other antiretroviral(s) (ARV), has been granted approval by the U.S. <a href=\"https:\/\/www.businesswire.com\/news\/home\/20221221005541\/en\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span>Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Sunlenca\u00ae (lenacapavir), in combination with other antiretroviral(s) (ARV), has been granted approval by the&#8230;<\/p>\n","protected":false},"author":1,"featured_media":21472,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[159],"tags":[],"class_list":{"0":"post-40163","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-hiv-2"},"jetpack_featured_media_url":"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/05\/GILEAD.jpg","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/40163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/comments?post=40163"}],"version-history":[{"count":1,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/40163\/revisions"}],"predecessor-version":[{"id":40164,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/40163\/revisions\/40164"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media\/21472"}],"wp:attachment":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media?parent=40163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/categories?post=40163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/tags?post=40163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}